 |
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Vivacta's platform is ideal for a wide range of immunoassays, including those requiring high sensitivity.
Vivacta's lead product is a TSH test for thyroid diagnosis – one of the most demanding immunoassays and where clinical benefit can be gained by more convenient testing and a closer linkage between diagnostics and therapy.
This is an example of how Vivacta's piezofilm sensor platform will allow tests previously confined to the laboratory to be conducted in the clinic or close to the patient's bedside.
With PoC testing being one of the fastest growing market sectors in diagnostics, Vivacta's platform creates the opportunity for diagnostic companies to translate central lab testing directly to the PoC.
Future applications include:
- Thyroid function
- Prostate
- Diabetes
- Cardiovascular
- Heart failure
- Heart markers
- Sepsis
- Acute renal
- High sensitivity infectious disease
IVD Technology
Developing an optically stimulated piezofilm immunoassay. Read more
Piezofilm Detection for Point-of-Care Imunoassay
A new, rapid, ultra-sensitive and non separation assay designed for point-of-care diagnostics. Read more
Vivacta gears up for pilot manufacture of piezofilm assays
10 July 2008
MTB Europe in vitro diagnostics company Vivacta is gearing up for pilot manufacture of its highly sensitive, disposable piezofilm sensors for point-of-care (PoC) diagnostics. Read more